David B. Olsen
35Patents
17h-index
93Co-inventors
84Inventor score
Filing activity: Aug 9, 1993 → Nov 16, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7125855B2 | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase | Emerging Cross-Sectional Technologies | 214 | Expired |
| US6777395B2 | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus | Emerging Cross-Sectional Technologies | 212 | Expired |
| US7105499B2 | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase | Emerging Cross-Sectional Technologies | 155 | Expired |
| US7202224B2 | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase | Emerging Cross-Sectional Technologies | 141 | Active |
| US5672695A | Modified ribozymes | Chemistry; Metallurgy | 127 | Expired |
| US7879815B2 | Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection | Human Necessities | 100 | Active |
| US5861501A | Capped synthetic RNA, analogs, and aptamers | Chemistry; Metallurgy | 88 | Expired |
| US7323453B2 | Methods of inhibiting orthopoxvirus replication with nucleoside compounds | Human Necessities | 67 | Expired |
| US7470664B2 | HCV NS3 protease inhibitors | Human Necessities | 49 | Active |
| US7323449B2 | Thionucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase | Chemistry; Metallurgy | 49 | Expired |
| US7632821B2 | Ribonucleoside cyclic acetal derivatives for the treatment of RNA-dependent RNA viral infection | Chemistry; Metallurgy | 48 | Active |
| US6111095A | Capped synthetic RNA, analogs, and aptamers | Chemistry; Metallurgy | 45 | Expired |
| US5698687A | Modified ribozymls | Chemistry; Metallurgy | 43 | Expired |
| US5817635A | Modified ribozymes | Chemistry; Metallurgy | 36 | Expired |
| US9061041B2 | 2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | Chemistry; Metallurgy | 32 | Active |
| US9156872B2 | 2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | Chemistry; Metallurgy | 28 | Active |
| US8216999B2 | HCV NS3 protease inhibitors | Human Necessities | 18 | Active |
| US6100028A | DNA polymerase extension assay | Chemistry; Metallurgy | 14 | Expired |
| US9777035B2 | 4′-substituted nucleoside reverse transcriptase inhibitors | Chemistry; Metallurgy | 9 | Active |
| US6369208B1 | Capped synthetic RNA, analogs, and aptamers | Chemistry; Metallurgy | 8 | Expired |
| US7879797B2 | HCV NS3 protease inhibitors | Chemistry; Metallurgy | 6 | Active |
| US9150603B2 | 2′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases | Emerging Cross-Sectional Technologies | 5 | Active |
| US10947205B2 | Oxazolidinone compounds and methods of use thereof as antibacterial agents | Chemistry; Metallurgy | 4 | Active |
| US9416154B2 | 5′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | Human Necessities | 2 | Active |
| US5660989A | DNA polymerase extension assay for influenza virus endonuclease | Chemistry; Metallurgy | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.